Company Focus

Novo Nordisk

Latest Novo Nordisk News

Number of patent disputes continue to grow in Russian pharma market
Generics
The number of patent disputes in the Russian pharmaceutical industry has almost doubled in the last several years, while these figures continue to grow these days, The Pharma Letter’s local correspondent reports.   16 July 2025


Insights

Company Spotlight

Latest News & Features of interest to Novo Nordisk

Latest In Brief for Novo Nordisk

Pharmaceutical
Ireland-based biopharma Jazz Pharmaceuticals has been called out for a couple of indiscretions by The Prescription Medicines Code of Practice Authority (PMCPA), which was established by the Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry.   11 July 2025

Latest Related Ones To Watch News

US pharma major AbbVie announced it plan to acquire Capstan Therapeutics, along with its autoimmune disease candidate CPTX2309, for up to $2.1 billion. Organon posted disappointing mid-stage trial results for its investigational endometriosis pain drug, OG-6219. Also of note last week, the US Food and drug Administration (FDA) granted accelerated approval for Regeneron’s multiple myeloma drug Lynozyfic.   6 July 2025

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search